|
1
|
Dang HX, Krasnick BA, White BS, Grossman
JG, Strand MS, Zhang J, Cabanski CR, Miller CA, Fulton RS,
Goedegebuure SP, et al: The clonal evolution of metastatic
colorectal cancer. Sci Adv. 6:eaay96912020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
GBD 2021 Diseases, Injuries Collaborators,
. Global incidence, prevalence, years lived with disability (YLDs),
disability-adjusted life-years (DALYs), and healthy life expectancy
(HALE) for 371 diseases and injuries in 204 countries and
territories and 811 subnational locations, 1990–2021: A systematic
analysis for the Global Burden of Disease Study 2021. Lancet.
403:2133–2161. 2024.PubMed/NCBI
|
|
3
|
Morgan E, Arnold M, Gini A, Lorenzoni V,
Cabasag CJ, Laversanne M, Vignat J, Ferlay J, Murphy N and Bray F:
Global burden of colorectal cancer in 2020 and 2040: Incidence and
mortality estimates from GLOBOCAN. Gut. 72:338–344. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Saffar KN, Larypoor M and Torbati MB:
Analyzing of colorectal cancerrelated genes and microRNAs
expression profiles in response to probiotics Lactobacillus
acidophilus and Saccharomyces cerevisiae in colon cancer cell
lines. Mol Biol Rep. 51:1222024. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Türk S, Yılmaz A, Safari Baesmat A, Malkan
UY, Ucar G and Türk C: The probiotic-induced disregulation of
immune-related genes in colon cells and relation with colorectal
cancer. Cell Mol Biol (Noisy-le-grand). 69:37–45. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Siegel RL, Wagle NS, Cercek A, Smith RA
and Jemal A: Colorectal cancer statistics, 2023. CA Cancer J Clin.
73:233–254. 2023.PubMed/NCBI
|
|
7
|
Matsuda A, Maruyama H, Akagi S, Inoue T,
Uemura K, Kobayashi M, Shiomi H, Watanabe M, Arai H, Kojima Y, et
al: Do postoperative infectious complications really affect
long-term survival in colorectal cancer surgery? A multicenter
retrospective cohort study. Ann Gastroenterol Surg. 7:110–120.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Guo J, Zhou B, Niu Y, Liu L and Yang L:
Engineered probiotics introduced to improve intestinal microecology
for the treatment of chronic diseases: present state and
perspectives. J Diabetes Metab Disord. 22:1029–1038. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim SH and Lim YJ: The role of microbiome
in colorectal carcinogenesis and its clinical potential as a target
for cancer treatment. Intest Res. 20:31–42. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang X, Pan L, Wang F, Long F, Yang B and
Tang D: Interventional effects of oral microecological agents on
perioperative indicators of colorectal cancer: A meta-analysis.
Front Oncol. 13:12291772023. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Khorashadizadeh S, Abbasifar S, Yousefi M,
Fayedeh F and Moodi Ghalibaf A: The role of microbiome and
probiotics in chemo-radiotherapy-induced diarrhea: A narrative
review of the current evidence. Cancer Rep (Hoboken).
7:e700292024.PubMed/NCBI
|
|
12
|
He Z, Xie H, Xu H, Wu J, Zeng W, He Q,
Jobin C, Jin S and Lan P: Chemotherapy-induced microbiota
exacerbates the toxicity of chemotherapy through the suppression of
interleukin-10 from macrophages. Gut Microbes. 16:23195112024.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Imanbayev N, Iztleuov Y, Bekmukhambetov Y,
Abdelazim IA, Donayeva A, Amanzholkyzy A, Aigul Z, Aigerim I and
Aslan Y: Colorectal cancer and microbiota: Systematic review. Prz
Gastroenterol. 16:380–396. 2024.PubMed/NCBI
|
|
14
|
Sanders ME, Merenstein DJ, Reid G, Gibson
GR and Rastall RA: Probiotics and prebiotics in intestinal health
and disease: from biology to the clinic. Nat Rev Gastroenterol
Hepatol. 16:605–616. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Azcárate-Peril MA, Sikes M and
Bruno-Bárcena JM: The intestinal microbiota, gastrointestinal
environment and colorectal cancer: A putative role for probiotics
in prevention of colorectal cancer? Am J Physiol Gastrointest Liver
Physiol. 301:G401–G424. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Paolillo R, Romano Carratelli C,
Sorrentino S, Mazzola N and Rizzo A: Immunomodulatory effects of
Lactobacillus plantarum on human colon cancer cells. Int
Immunopharmacol. 9:1265–1271. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yuan L, Zhang S, Li H, Yang F, Mushtaq N,
Ullah S, Shi Y, An C and Xu J: The influence of gut microbiota
dysbiosis to the efficacy of 5-Fluorouracil treatment on colorectal
cancer. Biomed Pharmacother. 108:184–193. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kumar A, Pramanik J, Batta K, Bamal P,
Gaur M, Rustagi S, Prajapati BG and Bhattacharya S: Impact of
metallic nanoparticles on gut microbiota modulation in colorectal
cancer: A review. Cancer Innov. 3:e1502024. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao J, Liao Y, Wei C, Ma Y, Wang F, Chen
Y, Zhao B, Ji H, Wang D and Tang D: Potential ability of probiotics
in the prevention and treatment of colorectal cancer. Clin Med
Insights Oncol. 17:117955492311882252023. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu J, Ma X, Wang X, Zhu G, Wang H, Zhang Y
and Li J: Efficacy and safety of compound kushen injection for
advanced colorectal cancer: A systematic review and meta-analysis
of randomized clinical trials with trial sequential analysis.
Integr Cancer Ther. 23:153473542412584582024. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Higgins JP, Savovic J and Page MJ: Chapter
8: Assessing risk of bias in a randomized trial. Cochrane Handbook
for Systematic Reviews of Interventions version 6.2. Higgins JP,
Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al: Cochrane;
2021, Available from:. training.cochrane.org/handbook
|
|
22
|
Weng H, Li S and Zeng XT: Application of
the trial sequential analysis soft ware for meta-analysis. Chin J
Evid-Based Med. 16:604–611. 2016.(In Chinese).
|
|
23
|
Bajramagic S, Hodzic E, Mulabdic A, Holjan
S, Smajlovic SV and Rovcanin A: Usage of probiotics and its
clinical significance at surgically treated patients sufferig from
colorectal carcinoma. Med Arch. 73:316–320. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen H, Xia Y, Shi C, Liang Y, Yang Y and
Qin H: Effects of perioperative probiotics administration on
patients with colorectal cancer. Chin J Clin Nutr. 22:82014.(In
Chinese).
|
|
25
|
Consoli ML, da Silva RS, Nicoli JR,
Bruña-Romero O, da Silva RG, de Vasconcelos Generoso S and Correia
MI: Randomized clinical trial: Impact of oral administration of
saccharomyces boulardii on gene expression of intestinal cytokines
in patients undergoing colon resection. JPEN J Parenter Enteral
Nutr. 40:1114–1121. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang F, Li S, Chen W, Han Y, Yao Y, Yang
L, Li Q, Xiao Q, Wei J, Liu Z, et al: Postoperative Probiotics
administration attenuates gastrointestinal complications and gut
microbiota dysbiosis caused by chemotherapy in colorectal cancer
patients. Nutrients. 15:3562023. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kotzampassi K, Stavrou G, Damoraki G,
Georgitsi M, Basdanis G, Tsaousi G and Giamarellos-Bourboulis EJ: A
Four-Probiotics regimen reduces postoperative complications after
colorectal surgery: A randomized, double-blind, placebo-controlled
study. World J Surg. 39:2776–2783. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu Z, Qin H, Yang Z, Xia Y, Liu W, Yang
J, Jiang Y, Zhang H, Yang Z, Wang Y and Zheng Q: Randomised
clinical trial: The effects of perioperative probiotic treatment on
barrier function and post-operative infectious complications in
colorectal cancer surgery - a double-blind study. Aliment Pharmacol
Ther. 33:50–63. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu ZH, Huang MJ, Zhang XW, Wang L, Huang
NQ, Peng H, Lan P, Peng JS, Yang Z, Xia Y, et al: The effects of
perioperative probiotic treatment on serum zonulin concentration
and subsequent postoperative infectious complications after
colorectal cancer surgery: A double-center and double-blind
randomized clinical trial. Am J Clin Nutr. 97:117–126. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu Z, Li C, Huang M, Tong C, Zhang X,
Wang L, Peng H, Lan P, Zhang P, Huang N, et al: Positive regulatory
effects of perioperative probiotic treatment on postoperative liver
complications after colorectal liver metastases surgery: A
double-center and double-blind randomized clinical trial. BMC
Gastroenterol. 15:342015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mangell P, Thorlacius H, Syk I, Ahrné S,
Molin G, Olsson C and Jeppsson B: Lactobacillus plantarum 299v does
not reduce enteric bacteria or bacterial translocation in patients
undergoing colon resection. Dig Dis Sci. 57:1915–1924. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mizuta M, Endo I, Yamamoto S, Inokawa H,
Kubo M, Udaka T, Sogabe O, Maeda H, Shirakawa K, Okazaki E, et al:
Perioperative supplementation with bifidobacteria improves
postoperative nutritional recovery, inflammatory response, and
fecal microbiota in patients undergoing colorectal surgery: A
prospective, randomized clinical trial. Biosci Microbiota Food
Health. 35:77–87. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Park IJ, Lee JH, Kye BH, Oh HK, Cho YB,
Kim YT, Kim JY, Sung NY, Kang SB, Seo JM, et al: Effects of
probiotics on the symptoms and surgical ouTComes after anterior
REsection of colon cancer (POSTCARE): A randomized, double-blind,
placebo-controlled trial. J Clin Med. 9:21812020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pellino G, Sciaudone G, Candilio G,
Camerlingo A, Marcellinaro R, De Fatico S, Rocco F, Canonico S,
Riegler G and Selvaggi F: Early postoperative administration of
probiotics versus placebo in elderly patients undergoing elective
colorectal surgery: A double-blind randomized controlled trial. BMC
Surg. 13 (Suppl 2):S572013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Rodríguez-Padilla Á, Morales-Martín G,
Pérez-Quintero R, Gómez-Salgado J, Balongo-García R and Ruiz-Frutos
C: Postoperative ileus after stimulation with probiotics before
ileostomy closure. Nutrients. 13:6262021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sadahiro S, Suzuki T, Tanaka A, Okada K,
Kamata H, Ozaki T and Koga Y: Comparison between oral antibiotics
and probiotics as bowel preparation for elective colon cancer
surgery to prevent infection: Prospective randomized trial.
Surgery. 155:493–503. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tan CK, Said S, Rajandram R, Wang Z,
Roslani AC and Chin KF: Pre-surgical administration of microbial
cell preparation in colorectal cancer patients: A randomized
controlled trial. World J Surg. 40:1985–1992. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xia Y, Yang Z, Chen HQ and Qin HL: Effect
of bowel preparation with probiotics on intestinal barrier after
surgery for colorectal cancer. Zhonghua Wei Chang Wai Ke Za Zhi.
13:528–531. 2010.(In Chinese). PubMed/NCBI
|
|
39
|
Xu Q, Xu P, Cen Y and Li W: Effects of
preoperative oral administration of glucose solution combined with
postoperative probiotics on inflammation and intestinal barrier
function in patients after colorectal cancer surgery. Oncol Lett.
18:694–698. 2019.PubMed/NCBI
|
|
40
|
Yang Y, Xia Y, Chen H, Hong L, Feng J,
Yang J, Yang Z, Shi C, Wu W, Gao R, et al: The effect of
perioperative probiotics treatment for colorectal cancer:
short-term outcomes of a randomized controlled trial. Oncotarget.
7:8432–8440. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zaharuddin L, Mokhtar NM, Muhammad Nawawi
KN and Raja Ali RA: A randomized double-blind placebo-controlled
trial of probiotics in post-surgical colorectal cancer. BMC
Gastroenterol. 19:1312019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang W, Du P, Chen D, Cui L and Ying C:
Effect of viable bifidobacterium supplementon theimmune statusand
inflanunatory response inpatients undergoing resection for
colorectal cancer. Chin J Gastrointest Surg. 13:40. 2010.
|
|
43
|
Zhang JW, Du P, Gao J, Yang BR, Fang WJ
and Ying CM: Preoperative probiotics decrease postoperative
infectious complications of colorectal cancer. Am J Med Sci.
343:199–205. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yu J, Nong C, Zhao J, Meng L and Song J:
An integrative bioinformatic analysis of microbiome and
transcriptome for predicting the risk of colon adenocarcinoma. Dis
Markers. 2022:79940742022. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Chang H, Lei L, Zhou Y, Ye F and Zhao G:
Dietary flavonoids and the risk of colorectal cancer: An updated
meta-analysis of epidemiological studies. Nutrients. 10:9502018.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Al-Nemari R, Al-Senaidy A, Semlali A,
Ismael M, Badjah-Hadj-Ahmed AY and Ben Bacha A: GC-MS profiling and
assessment of antioxidant, antibacterial, and anticancer properties
of extracts of Annona squamosa L. leaves. BMC Complement Med Ther.
20:2962020. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Gopalakrishnan V, Spencer CN, Nezi L,
Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman
K, Wei SC, et al: Gut microbiome modulates response to anti-PD-1
immunotherapy in melanoma patients. Science. 359:97–103. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wong CC and Yu J: Gut microbiota in
colorectal cancer development and therapy. Nat Rev Clin Oncol.
20:429–452. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Sun L, Zhu Z, Jia X, Ying X, Wang B, Wang
P, Zhang S and Yu J: The difference of human gut microbiome in
colorectal cancer with and without metastases. Front Oncol.
12:9827442022. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhang W, An Y, Qin X, Wu X, Wang X, Hou H,
Song X, Liu T, Wang B, Huang X and Cao H: Gut microbiota-derived
metabolites in colorectal cancer: The bad and the challenges. Front
Oncol. 11:7396482021. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Hill C, Guarner F, Reid G, Gibson GR,
Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S,
et al: Expert consensus document. The international scientific
association for probiotics and prebiotics consensus statement on
the scope and appropriate use of the term probiotic. Nat Rev
Gastroenterol Hepatol. 11:506–514. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Suez J, Zmora N, Segal E and Elinav E: The
pros, cons, and many unknowns of probiotics. Nat Med. 25:716–729.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Sonnenburg JL and Bäckhed F:
Diet-microbiota interactions as moderators of human metabolism.
Nature. 535:56–64. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Szajewska H and Kołodziej M: Systematic
review with meta-analysis: Saccharomyces boulardii in the
prevention of antibiotic-associated diarrhoea. Aliment Pharmacol
Ther. 42:793–801. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Szajewska H, Guarino A, Hojsak I, Indrio
F, Kolacek S, Shamir R, Vandenplas Y and Weizman Z; European
Society for Pediatric Gastroenterology, Hepatology, Nutrition, :
Use of probiotics for management of acute gastroenteritis: A
position paper by the ESPGHAN Working Group for Probiotics and
Prebiotics. J Pediatr Gastroenterol Nutr. 58:531–539. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Cani PD and Jordan BF: Gut
microbiota-mediated inflammation in obesity: A link with
gastrointestinal cancer. Nat Rev Gastroenterol Hepatol. 15:671–682.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Huang HC, Cai BH, Suen CS, Lee HY, Hwang
MJ, Liu FT and Kannagi R: BGN/TLR4/NF-B mediates epigenetic
silencing of immunosuppressive siglec ligands in colon cancer
cells. Cells. 9:3972020. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Wu R, Shen Q, Li P and Shang N: Sturgeon
chondroitin sulfate restores the balance of gut microbiota in
colorectal cancer bearing mice. Int J Mol Sci. 23:37232022.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Persson JE, Viana P, Persson M, Relvas JH
and Danielski LG: Perioperative or postoperative probiotics reduce
treatment-related complications in adult colorectal cancer patients
undergoing surgery: A systematic review and meta-analysis. J
Gastrointest Cancer. 55:740–748. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
An S, Kim K, Kim MH, Jung JH and Kim Y:
Perioperative probiotics application for preventing postoperative
complications in patients with colorectal cancer: A systematic
review and meta-analysis. Medicina (Kaunas). 58:16442022.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Araújo MM, Montalvão-Sousa TM, Teixeira
PDC, Figueiredo ACMG and Botelho PB: The effect of probiotics on
postsurgical complications in patients with colorectal cancer: A
systematic review and meta-analysis. Nutr Rev. 81:493–510. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Chen C, Wen T and Zhao Q: Probiotics used
for postoperative infections in patients undergoing colorectal
cancer surgery. Biomed Res Int. 2020:57347182020. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Chen Y, Qi A, Teng D, Li S, Yan Y, Hu S
and Du X: Probiotics and synbiotics for preventing postoperative
infectious complications in colorectal cancer patients: A
systematic review and meta-analysis. Tech Coloproctol. 26:425–436.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Jaye K, Li CG and Bhuyan DJ: The complex
interplay of gut microbiota with the five most common cancer types:
From carcinogenesis to therapeutics to prognoses. Crit Rev Oncol
Hematol. 165:1034292021. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Iida N, Dzutsev A, Stewart CA, Smith L,
Bouladoux N, Weingarten RA, Molina DA, Salcedo R, Back T, Cramer S,
et al: Commensal bacteria control cancer response to therapy by
modulating the tumor microenvironment. Science. 342:967–970. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Routy B, Le Chatelier E, Derosa L, Duong
CPM, Alou MT, Daillère R, Fluckiger A, Messaoudene M, Rauber C,
Roberti MP, et al: Gut microbiome influences efficacy of PD-1-based
immunotherapy against epithelial tumors. Science. 359:91–97. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Belkaid Y and Hand TW: Role of the
microbiota in immunity and inflammation. Cell. 157:121–41. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Zhang F, Aschenbrenner D, Yoo JY and Zuo
T: The gut mycobiome in health, disease, and clinical applications
in association with the gut bacterial microbiome assembly. Lancet
Microbe. 3:e969–e983. 2022. View Article : Google Scholar : PubMed/NCBI
|
